CLINICAL_TRIALS
trial_result
· 2025-09-04
Clinical Trial Update: A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease [Phase 2]
Summary
Phase 2 trial evaluating BI 706321 in combination with ustekinumab for Crohn's disease was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Crohn Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-09-04